Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study
Corona virus disease-19 (COVID-19) vaccines have been approved for emergency use. Ocular adverse effects following the vaccines have been reported. Purpose: To report an unique case of recurrent central serous chorioretinopathy following both doses of COVID-19 vaccine. Observations: A 40-year-old ma...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | American Journal of Ophthalmology Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2451993622003905 |
| _version_ | 1817998226765119488 |
|---|---|
| author | Srinivasan Sanjay Isha Acharya Ankush Kawali Rohit Shetty Padmamalini Mahendradas |
| author_facet | Srinivasan Sanjay Isha Acharya Ankush Kawali Rohit Shetty Padmamalini Mahendradas |
| author_sort | Srinivasan Sanjay |
| collection | DOAJ |
| description | Corona virus disease-19 (COVID-19) vaccines have been approved for emergency use. Ocular adverse effects following the vaccines have been reported. Purpose: To report an unique case of recurrent central serous chorioretinopathy following both doses of COVID-19 vaccine. Observations: A 40-year-old male presented with blurring of vision in the left eye during 2 days following COVISHIELD™ (Serum Institute of India). He had a previous history of central serous chorioretinopathy in the right eye 2 years back and was treated with micropulse laser. Ocular examination showed a best corrected visual acuity of 20/20 right eye and 20/60 left eye. Fundus evaluation of left eye showed central serous chorioretinopathy. Spectral domain optical coherence tomography of the left eye revealed neurosensory detachment. Fundus fluorescein angiography of the left eye showed multiple window defects and ink-blot appearance in the macula. Oral eplerenone 50mg once a day for a month showed significant reduction in the subretinal fluid. Patient developed central serous chorioretinopathy in the left eye 3 days after 2nd dose of COVISHIELD™. Conclusion and Importance: CSCR following vaccination may be a temporal event. In our patient it occurred following the vaccination. This is the first case of a recurrent CSCR after either dose of COVID-19 vaccination. Ocular symptoms after vaccination warrant a thorough eye evaluation. |
| first_indexed | 2024-04-14T02:50:57Z |
| format | Article |
| id | doaj.art-18dbd00c60014c98ac562e3d9a946b4b |
| institution | Directory Open Access Journal |
| issn | 2451-9936 |
| language | English |
| last_indexed | 2024-04-14T02:50:57Z |
| publishDate | 2022-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | American Journal of Ophthalmology Case Reports |
| spelling | doaj.art-18dbd00c60014c98ac562e3d9a946b4b2022-12-22T02:16:18ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362022-09-0127101644Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging studySrinivasan Sanjay0Isha Acharya1Ankush Kawali2Rohit Shetty3Padmamalini Mahendradas4Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, India; Corresponding author. 121/C, Chord Road, Narayana Nethralaya, Bangalore, India.Department of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, IndiaDepartment of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, IndiaDepartments of Cornea, Refractive Surgery and Neuro-Ophthalmology Narayana Nethralaya, Bangalore, IndiaDepartment of Uveitis and Ocular Immunology, Narayana Nethralaya, Bangalore, IndiaCorona virus disease-19 (COVID-19) vaccines have been approved for emergency use. Ocular adverse effects following the vaccines have been reported. Purpose: To report an unique case of recurrent central serous chorioretinopathy following both doses of COVID-19 vaccine. Observations: A 40-year-old male presented with blurring of vision in the left eye during 2 days following COVISHIELD™ (Serum Institute of India). He had a previous history of central serous chorioretinopathy in the right eye 2 years back and was treated with micropulse laser. Ocular examination showed a best corrected visual acuity of 20/20 right eye and 20/60 left eye. Fundus evaluation of left eye showed central serous chorioretinopathy. Spectral domain optical coherence tomography of the left eye revealed neurosensory detachment. Fundus fluorescein angiography of the left eye showed multiple window defects and ink-blot appearance in the macula. Oral eplerenone 50mg once a day for a month showed significant reduction in the subretinal fluid. Patient developed central serous chorioretinopathy in the left eye 3 days after 2nd dose of COVISHIELD™. Conclusion and Importance: CSCR following vaccination may be a temporal event. In our patient it occurred following the vaccination. This is the first case of a recurrent CSCR after either dose of COVID-19 vaccination. Ocular symptoms after vaccination warrant a thorough eye evaluation.http://www.sciencedirect.com/science/article/pii/S2451993622003905COVID-19 vaccinationCOVISHIELD™Central serous chorioretinopathySpectral domain optical coherence tomographyEplerenone |
| spellingShingle | Srinivasan Sanjay Isha Acharya Ankush Kawali Rohit Shetty Padmamalini Mahendradas Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study American Journal of Ophthalmology Case Reports COVID-19 vaccination COVISHIELD™ Central serous chorioretinopathy Spectral domain optical coherence tomography Eplerenone |
| title | Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study |
| title_full | Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study |
| title_fullStr | Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study |
| title_full_unstemmed | Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study |
| title_short | Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study |
| title_sort | unilateral recurrent central serous chorioretinopathy cscr following covid 19 vaccination a multimodal imaging study |
| topic | COVID-19 vaccination COVISHIELD™ Central serous chorioretinopathy Spectral domain optical coherence tomography Eplerenone |
| url | http://www.sciencedirect.com/science/article/pii/S2451993622003905 |
| work_keys_str_mv | AT srinivasansanjay unilateralrecurrentcentralserouschorioretinopathycscrfollowingcovid19vaccinationamultimodalimagingstudy AT ishaacharya unilateralrecurrentcentralserouschorioretinopathycscrfollowingcovid19vaccinationamultimodalimagingstudy AT ankushkawali unilateralrecurrentcentralserouschorioretinopathycscrfollowingcovid19vaccinationamultimodalimagingstudy AT rohitshetty unilateralrecurrentcentralserouschorioretinopathycscrfollowingcovid19vaccinationamultimodalimagingstudy AT padmamalinimahendradas unilateralrecurrentcentralserouschorioretinopathycscrfollowingcovid19vaccinationamultimodalimagingstudy |